ARAY
Price
$1.69
Change
-$0.07 (-3.98%)
Updated
Oct 17 closing price
Capitalization
190.5M
10 days until earnings call
SSKN
Price
$1.89
Change
-$0.19 (-9.13%)
Updated
Oct 17 closing price
Capitalization
10.74M
Interact to see
Advertisement

ARAY vs SSKN

Header iconARAY vs SSKN Comparison
Open Charts ARAY vs SSKNBanner chart's image
Accuray
Price$1.69
Change-$0.07 (-3.98%)
Volume$847.45K
Capitalization190.5M
Strata Skin Sciences
Price$1.89
Change-$0.19 (-9.13%)
Volume$318.41K
Capitalization10.74M
ARAY vs SSKN Comparison Chart in %
ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SSKN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARAY vs. SSKN commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAY is a Hold and SSKN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (ARAY: $1.69 vs. SSKN: $1.89)
Brand notoriety: ARAY and SSKN are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ARAY: 95% vs. SSKN: 5%
Market capitalization -- ARAY: $190.5M vs. SSKN: $10.74M
ARAY [@Medical/Nursing Services] is valued at $190.5M. SSKN’s [@Medical/Nursing Services] market capitalization is $10.74M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $223.72B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARAY’s FA Score shows that 0 FA rating(s) are green whileSSKN’s FA Score has 0 green FA rating(s).

  • ARAY’s FA Score: 0 green, 5 red.
  • SSKN’s FA Score: 0 green, 5 red.
According to our system of comparison, ARAY is a better buy in the long-term than SSKN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARAY’s TA Score shows that 4 TA indicator(s) are bullish while SSKN’s TA Score has 4 bullish TA indicator(s).

  • ARAY’s TA Score: 4 bullish, 4 bearish.
  • SSKN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ARAY is a better buy in the short-term than SSKN.

Price Growth

ARAY (@Medical/Nursing Services) experienced а -4.52% price change this week, while SSKN (@Medical/Nursing Services) price change was +22.73% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.22%. For the same industry, the average monthly price growth was +3.46%, and the average quarterly price growth was +18.56%.

Reported Earning Dates

ARAY is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Medical/Nursing Services (+1.22% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARAY($190M) has a higher market cap than SSKN($10.7M). ARAY YTD gains are higher at: -14.646 vs. SSKN (-35.052). ARAY has higher annual earnings (EBITDA): 20.2M vs. SSKN (-4.44M). ARAY has more cash in the bank: 57.4M vs. SSKN (5.97M). SSKN has less debt than ARAY: SSKN (16.4M) vs ARAY (176M). ARAY has higher revenues than SSKN: ARAY (459M) vs SSKN (32.8M).
ARAYSSKNARAY / SSKN
Capitalization190M10.7M1,776%
EBITDA20.2M-4.44M-455%
Gain YTD-14.646-35.05242%
P/E RatioN/AN/A-
Revenue459M32.8M1,399%
Total Cash57.4M5.97M962%
Total Debt176M16.4M1,073%
FUNDAMENTALS RATINGS
ARAY vs SSKN: Fundamental Ratings
ARAY
SSKN
OUTLOOK RATING
1..100
7550
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
56
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
93100
PRICE GROWTH RATING
1..100
4753
P/E GROWTH RATING
1..100
41100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SSKN's Valuation (56) in the Medical Specialties industry is in the same range as ARAY (85). This means that SSKN’s stock grew similarly to ARAY’s over the last 12 months.

SSKN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ARAY (100). This means that SSKN’s stock grew similarly to ARAY’s over the last 12 months.

ARAY's SMR Rating (93) in the Medical Specialties industry is in the same range as SSKN (100). This means that ARAY’s stock grew similarly to SSKN’s over the last 12 months.

ARAY's Price Growth Rating (47) in the Medical Specialties industry is in the same range as SSKN (53). This means that ARAY’s stock grew similarly to SSKN’s over the last 12 months.

ARAY's P/E Growth Rating (41) in the Medical Specialties industry is somewhat better than the same rating for SSKN (100). This means that ARAY’s stock grew somewhat faster than SSKN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARAYSSKN
RSI
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 11 days ago
75%
Bullish Trend 17 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 10 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
68%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SSKN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AWR75.470.20
+0.27%
American States Water Company
GWRE244.280.47
+0.19%
Guidewire Software
GDYN7.59-0.07
-0.91%
Grid Dynamics Holdings
ATOS0.98-0.05
-4.89%
Atossa Therapeutics
ZONE1.32-0.10
-7.04%
CleanCore Solutions

ARAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARAY has been loosely correlated with ILMN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ARAY jumps, then ILMN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARAY
1D Price
Change %
ARAY100%
-3.98%
ILMN - ARAY
41%
Loosely correlated
-0.47%
A - ARAY
41%
Loosely correlated
+0.58%
INMD - ARAY
41%
Loosely correlated
+0.59%
GKOS - ARAY
41%
Loosely correlated
+2.16%
QDEL - ARAY
41%
Loosely correlated
-1.02%
More

SSKN and

Correlation & Price change

A.I.dvisor tells us that SSKN and VERO have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SSKN and VERO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SSKN
1D Price
Change %
SSKN100%
-9.13%
VERO - SSKN
30%
Poorly correlated
-2.13%
DCTH - SSKN
26%
Poorly correlated
-3.16%
IVF - SSKN
25%
Poorly correlated
-46.30%
ANIK - SSKN
25%
Poorly correlated
+0.88%
ARAY - SSKN
22%
Poorly correlated
-3.98%
More